Concepedia

Victor M. Rivera

VM

128

Publications

15K

Citations

56

H-Index

1986

Active since

Affiliations

Ariadne Diagnostics (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of Michigan

University of California, San Francisco

Michigan Center for Translational Pathology

Victor M. Rivera is an author at Ariadne Diagnostics (United States) specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

1986–2022

128

Publications

128

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu et al. · Cancer Cell · 2009 · 1.2K citations · Full text

, , +9

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah et al. · New England Journal of Medicine · 2012 · 759 citations · Full text

Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz et al. · Blood · 2018 · 572 citations · Full text

A humanized system for pharmacologic control of gene expression

Victor M. Rivera, Tim Clackson, Sridaran Natesan et al. · Nature Medicine · 1996 · 541 citations

, , +4

Rows per page

1–5 of 128